Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
VanEck Oil Services ETF
OIH
5
ProShares Ultra Energy
DIG
US Stock MarketDetailed Quotes
Enliven Therapeutics (ELVN)
- 46.130
- +5.770+14.30%
Close Jun 12 15:59 ET
- 45.470
- -0.660-1.43%
Post 20:01 ET
2.81BMarket Cap-28.13P/E (TTM)
47.360High39.000Low6.15MVolume39.765Open40.360Prev Close272.34MTurnover13.83%Turnover RatioLossP/E (Static)60.90MShares48.53052wk High6.20P/B2.05BFloat Cap14.78552wk Low--Dividend TTM44.43MShs Float250.840Historical High--Div Yield TTM20.71%Range %3.896Historical Low44.312Avg Price1Lot Size
Enliven Therapeutics (ELVN) Key Financial Indicators
ELVN Earnings per Share (EPS)
According to the latest financial report of Enliven Therapeutics, the latest earnings per share (TTM) for the company is -0.38. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
ELVN Free Cash Flow (FCF)
Interested in knowing about Enliven Therapeutics's free cash flow? The latest report shows it as -19.29M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
ELVN Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Enliven Therapeutics shows that the company's current ratio is 40.32, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
ELVN Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Enliven Therapeutics, the quick ratio is 39.38, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ELVN Return on Equity (ROE)
Want to learn more about the financial health of Enliven Therapeutics? The latest ROE figure is -5.18%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ELVN Return on Assets (ROA)
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Enliven Therapeutics, the total asset return on investment (ROA) is -5.02%.
Currency: USD
Quarterly
Loading...
ELVN Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Enliven Therapeutics's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
ELVN Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Enliven Therapeutics, the net profit margin is --, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
The U.S.-Iran peace talks have entered a critical window! On the 14th, Iranian sources indicated that Pakistan will host a video conference
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm